The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $72.71

Today's change-0.24 -0.33%
Updated May 6 1:57 PM EDT. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $72.71

Today's change-0.24 -0.33%
Updated May 6 1:57 PM EDT. Delayed by at least 15 minutes.

Express Scripts Holding Co crosses below 20-day moving average

Express Scripts Holding Co is lower today, dropping (U.S.)$0.24 or 0.33% to (U.S.)$72.71 and crossing below its 20-day moving average. Over the last five days, shares have lost 1.38% and are down 16.82% for the last year to date. This security has underperformed the S&P 500 by 12.13% during the last year.

Key company metrics

  • Open(U.S.) $72.51
  • Previous close(U.S.) $72.95
  • High(U.S.) $73.43
  • Low(U.S.) $72.14
  • Bid / Ask(U.S.) $72.70 / (U.S.) $72.72
  • YTD % change-16.82%
  • Volume1,550,530
  • Average volume (10-day)3,948,307
  • Average volume (1-month)4,465,741
  • Average volume (3-month)5,285,657
  • 52-week range(U.S.) $65.55 to (U.S.) $94.61
  • Beta1.37
  • Trailing P/E19.17×
  • P/E 1 year forward11.47×
  • Forward PEG0.73×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.79
Updated May 6 1:57 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.54%

Based on its net profit margin of 2.54%, Express Scripts Holding Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue24,79226,17525,22325,454
Total other revenue--------
Total revenue24,79226,17525,22325,454
Gross profit1,8472,3412,2192,172
Total cost of revenue22,94523,83523,00423,282
Total operating expense23,85124,96224,05624,322
Selling / general / administrative906948939910
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--179113129
Other operating expenses, total--------
Operating income9411,2141,1661,133
Interest income (expense), net non-operating-139-123-128-132
Gain (loss) on sale of assets--------
Other--------
Income before tax8111,0961,0461,006
Income after tax532779667606
Income tax, total279317378400
Net income526774662600
Total adjustments to net income--------
Net income before extra. items526774662600
Minority interest-6-5-6-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items526774662600
Inc. avail. to common incl. extra. items526774662600
Diluted net income526774662600
Dilution adjustment0------
Diluted weighted average shares650683682681
Diluted EPS excluding extraordinary itemsvalue per share0.811.130.970.88
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.811.421.141.06